IRAK4 and neoplasm: Moreover, silencing the gene expression of IRAK-4 by shRNA or the application of small molecule inhibitors can induce the proliferation of tumor cells in patients with T-acute lymphoblastic leukemia, suggesting that the signaling mediated by IRAK-4 is an important factor in disease progression (23).